Skip to content
  1. Fuad El-Hibri and The National Health Museum September 30, 2010

    Posted in Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, National Health Museum.

    No comments
  2. Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine September 20, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.

    No comments
  3. Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine September 10, 2010

    Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Vaccine.

    No comments
    4. DeliciousDiggFacebook
    RSS FeedStumbleUponTwitter